
 
 
 
 
 
 
 
 
   
 1. A method of reducing and/or removing diglyceride from an edible oil, comprising a) admixing an edible oil with an acyl acceptor substrate and a fatty-acid CoA independent diglyceride:glycerol acyltransferase, wherein the fatty-acid CoA independent diglyceride:glycerol acyltransferase is characterized as an enzyme which in an edible oil transfers an acyl group from a diglyceride to glycerol.  
 
     
 2. A method according to claim 1 wherein the fatty-acid CoA independent diglyceride:glycerol acyltransferase comprises the amino acid sequence motif GDSX, wherein X is one or more of the following amino acid residues L, A, V, I, F, Y, H, Q, T, N, M or S.  
 
     
 3. A method according to claim 1 wherein the amount of diglyceride in the edible oil is reduced.  
 
     
 4. A method according to claim 1 or claim 2 wherein the fatty-acid CoA independent diglyceride:glycerol acyltransferase transfers an acyl group from a diglyceride to an acyl acceptor, wherein the acyl acceptor is any compound comprising a hydroxy group (-OH).  
 
     
 5. A method according any one of claims 1 to 4, wherein the diglyceride is a 1,2-diglyceride.  
 
     
 6. A method according to any one of the preceding claims wherein acyl acceptor is one which is soluble in an edible oil.  
 
     
 7. A method according to any one of the preceding claims wherein the acyl acceptor is an alcohol.  
 
     
 8. A method according to claim 7 wherein the acyl acceptor is an alcohol.  
 
     
 9. A method according to claim 8 wherein the acyl acceptor is glycerol.  
 
     
 10. A method according to any one of the preceding claims wherein the fatty-acid CoA independent diglyceride:glycerol acyltransferase enzyme comprises H-309 or comprises a histidine residue at a position corresponding to His-309 in the amino acid sequence of the Aeromonas hydrophila lipolytic enzyme shown as SEQ ID No. 2 or SEQ ID No. 32.  
 
     
 11. A method according to any one of the preceding claims wherein the fatty-acid CoA independent diglyceride:glycerol acyltransferase is obtainable from an organism from one or more of the following genera: Aeronaonas, Streptomyces, Saccharomyces, Lactococcus, Mycobacterium, Streptococcus, Lactobacillus, Desulfitobacterium, Bacillus, Campylobacter, Vibrionaceae, Xylella, Sulfolobus, Aspergillus, Schizosaccharomyces, Listeria, Neisseria, Mesorhizobium, Ralstonia, Xanthomonas and Candida.  
 
     
 12. A method according to any one of the preceding claims wherein the fatty-acid CoA independent diglyceride:glycerol acyltransferase comprises one or more of the following amino acid sequences: (i) the amino acid sequence shown as SEQ ID  No. 2; (ii) the amino acid sequence shown as SEQ ID No. 3; (iii) the amino acid sequence shown as SEQ ID No. 4; (iv) the amino acid sequence shown as SED ID No. 5; (v) the amino acid sequence shown as SEQ ID No. 6; (vi) the amino acid sequence shown as SEQ ID No. 12, (vii) the amino acid sequence shown as SEQ ID No. 20, (viii) the amino acid sequence shown as SEQ ID No. 22, (ix) the amino acid sequence shown as SEQ ID No. 24, (x) the amino acid sequence shown as SEQ ID No. 26, (xi) the amino acid sequence shown as SEQ ID No. 28, (xii) the amino acid sequence shown as SEQ ID No. 30, (xiii) the amino acid sequence shown as SEQ ID No. 32, (xiv) the amino acid sequence shown as SEQ ID No. 34, (xv) the amino acid sequence shown as SEQ ID no. 55; (xvi) the amino acid sequence shown as SEQ ID No. 58; (xvii) the amino acid sequence shown as SEQ ID No. 60; (xviii) the amino acid sequence shown as SEQ ID No. 61; (xix) the amino acid sequence shown as SEQ ID No. 63; (xx) the amino acid sequence shown as SEQ ID No. 65; (xxi) the amino acid sequence shown as SEQ ID No. 67; (xxii) the amino acid sequence shown as SEQ ID No. 70 or (xxiii) an amino acid sequence which has 75% or more identity with any one of the sequences shown as SEQ -ID No. 2, SEQ ID No. 3, SEQ ID No. 4, SEQ ID No. 5, SEQ ID No.  6, SEQ ID No. 12, SEQ ID No. 20, SEQ ID No. 22, SEQ ID No. 24, SEQ ID No. 26, SEQ ID No. 28, SEQ ID No. 30, SEQ ID No. 32, SEQ ID No. 34, SEQ ID No. 55, SEQ ID No. 58, SEQ ID No. 60, SEQ ID No. 61, SEQ ID No. 63, SEQ ID No. 65, SEQ ID No. 67 or SEQ ID No. 70.  
 
     
 13. A method according to any one of the preceding claims wherein the fatty-acid CoA independent diglyceride:glycerol acyltransferase comprises an amino acid sequence encoded by one or more of the following nucleotide sequences: (a) the nucleotide sequence shown as SEQ ID No. 7; (b) the nucleotide sequence shown as SEQ ID No. 8; (c) the nucleotide sequence shown as SEQ ID No. 9; (d) the nucleotide sequence shown as SEQ ID No. 10; (e) the nucleotide sequence shown as SEQ ID No. 11; (f) the nucleotide sequence shown as SEQ ID No. 13; (g) the nucleotide sequence shown as SEQ ID No. 21; (h) the nucleotide sequence shown as SEQ ID No. 23; (i) the nucleotide sequence shown as SEQ ID No. 25; (j) the nucleotide sequence shown as SEQ ID No. 27; (k) the nucleotide sequence shown as SEQ ID No. 29; (l) the nucleotide sequence shown as SEQ ID No. 31; (m)the nucleotide sequence shown as SEQ ID No. 33; (n) the nucleotide sequence shown as SEQ ID No. 35; (o) the nucleotide sequence shown as SEQ ID No. 54; (p) the nucleotide sequence shown as SEQ ID No. 59; (q) the nucleotide sequence shown as SEQ ID No. 62; (r) the nucleotide sequence shown as SEQ ID No. 64; (s) the nucleotide sequence shown as SEQ ID No. 66; (t) the nucleotide sequence shown as SEQ ID No. 68 (u) the nucleotide sequence shown as SEQ ID No. 69 or (v) a nucleotide sequence which has 75% or more identity with any one of the sequences shown as SEQ ID No. 7, SEQ ID No. 8, SEQ ID No. 9, SEQ ID No. 10, SEQ ID No. 11, SEQ ID No. 13, SEQ ID No. 21, SEQ ID No. 23, SEQ ID No. 25, SEQ ID No. 27, SEQ ID No. 29, SEQ ID No. 31, SEQ ID No. 33, SEQ ID No. 35, SEQ ID No. 54, SEQ ID No. 59, SEQ ID No. 62, SEQ ID No. 64, SEQ ID No. 66, SEQ ID No. 68 or SEQ ID No. 69.  
 
     
 14. A method according to any one of the preceding claims comprising admixing the treated edible oil with one or more food constituents to formulate a foodstuff.  
 
     
 15. Use of a fatty-acid CoA independent diglyceride:glycerol acyltransferase characterized as an enzyme which in an edible oil transfers an acyl group from a diglyceride to glycerol, in the manufacture of an edible oil, for reducing and/or removing (preferably selectively reducing and/or removing) diglyceride from said edible oil.  
 
     
 16. Use of a fatty-acid CoA independent diglyceride:glycerol acyltransferase characterized as an enzyme which in an edible oil transfers an acyl group from a diglyceride to glycerol, in the manufacture of a foodstuff comprising an edible oil for improving the crystallization properties of said foodstuff.  
 
     
 17. Use according claim 15 or claim 16 wherein the fatty-acid CoA independent diglyceride:glycerol acyltransferase comprises the amino acid sequence motif GDSX, wherein X is one or more of the following amino acid residues L, A, V, I, F, Y, H, Q, T, N, M or S.  
 
     
 18. Use according to any one of claims 15, 16 or 17 wherein the amount of diglyceride in the edible oil is reduced.  
 
     
 19. Use according to any one of claims 15 to 18 wherein the fatty-acid CoA independent diglyceride:glycerol acyltransferase transfers an acyl group from a diglyceride to an acyl acceptor, wherein the acyl acceptor is any compound comprising a hydroxy group (-OH).  
 
     
 20. Use according any one of claims 15 to 19, wherein the diglyceride is a 1,2-diglyceride.  
 
     
 21. Use according to any one of claims 15 to 20 wherein acyl acceptor is one which is soluble in an edible oil.  
 
     
 22. Use according to any one of claims 14-19 wherein the acyl acceptor is an alcohol.  
 
     
 23. Use according to claim 22 wherein the acyl acceptor is an alcohol.  
 
     
 24. Use according to claim 23 wherein the acyl acceptor is glycerol.  
 
     
 25. Use according to any one of claims 15-24 wherein the fatty-acid CoA independent diglyceride:glycerol acyltransferase enzyme comprises H-309 or comprises a histidine residue at a position corresponding to His-309 in the amino acid sequence of the Aeromonas hydrophila lipolytic enzyme shown as SEQ ID No. 2 or SEQ ID No. 32.  
 
     
 26. Use according to any one of claims 15-25 wherein the fatty-acid CoA independent diglyceride:glycerol acyltransferase is obtainable from an organism from one or more of the following genera: Aeromonas, Streptomyces, Saccharomyces, Lactococcus, Mycobacterium, Streptococcus, Lactobacillus, Desulfitobacterium, Bacillus, Campylobacter, Vibrionaceae, Xylella, Sulfolobus, Aspergillus, Schizosaccharomyces, Listeria, Neisseria, Mesorhizobium, Ralstonia, Xanthornonas and Candida.  
 
     
 27. Use according to any one of claims 15-26 wherein the fatty-acid CoA independent diglyceride:glycerol acyltransferase comprises one or more of the following amino acid sequences: (i) the amino acid sequence shown as SEQ ID  No. 2; (ii) the amino acid sequence shown as SEQ ID No. 3; (iii) the amino acid sequence shown as SEQ ID No. 4; (iv) the amino acid sequence shown as SED ID No. 5; (v) the amino acid sequence shown as SEQ ID No. 6; (vi) the amino acid sequence shown as SEQ ID No. 12, (vii) the amino acid sequence shown as SEQ ID No. 20, (viii) the amino acid sequence shown as SEQ ID No. 22, (ix) the amino acid sequence shown as SEQ ID No. 24, (x) the amino acid sequence shown as SEQ ID No. 26, (xi) the amino acid sequence shown as SEQ ID No. 28, (xii) the amino acid sequence shown as SEQ ID No. 30, (xiii) the amino acid sequence shown as SEQ ID No. 32, (xiv) the amino acid sequence shown as SEQ ID No. 34, (xv) the amino acid sequence shown as SEQ ID No. 55; (xvi) the amino acid sequence shown as SEQ ID No. 58; (xvii) the amino acid sequence shown as SEQ ID No. 60; (xviii) the amino acid sequence shown as SEQ ID No. 61; (xix) the amino acid sequence shown as SEQ ID No. 63; (xx) the amino acid sequence shown as SEQ ID No. 65; (xxi) the amino acid sequence shown as SEQ ID No. 67; (xxii) the amino acid sequence shown as SEQ ID No. 70 or (xxiii) an amino acid sequence which has 75% or more identity with any one of the sequences shown as SEQ ID No. 2, SEQ ID No. 3, SEQ ID No. 4, SEQ ID No. 5, SEQ ID No. 6, SEQ ID No. 12; SEQ ID No. 20, SEQ ID No. 22, SEQ ID No. 24, SEQ ID No. 26, SEQ ID No. 28, SEQ ID No. 30, SEQ ID No. 32, SEQ ID No. 34, SEQ ID No. 55, SEQ ID No. 58, SEQ ID No. 60, SEQ ID No. 61, SEQ ID No. 63, SEQ ID No. 65, SEQ ID No. 67 or SEQ ID No. 70.  
 
     
 28. Use according to any one of claims 15-27 wherein the fatty-acid CoA independent diglyceride:glycerol acyltransferase comprises an amino acid sequence encoded by one or more of the following nucleotide sequences: (a) the nucleotide sequence shown as SEQ ID No. 7; (b) the nucleotide sequence shown as SEQ ID No. 8; (c) the nucleotide sequence shown as SEQ ID No. 9; (d) the nucleotide sequence shown as SEQ ID No. 10; (e) the nucleotide sequence shown as SEQ ID No. 11; (f) the nucleotide sequence shown as SEQ ID No. 13; (g) the nucleotide sequence shown as SEQ ID No. 21; (h) the nucleotide sequence shown as SEQ ID No. 23; (i) the nucleotide sequence shown as SEQ ID No. 25; (j) the nucleotide sequence shown as SEQ ID No. 27; (k) the nucleotide sequence shown as SEQ ID No. 29; (l) the nucleotide sequence shown as SEQ ID No. 31; (m)the nucleotide sequence shown as SEQ ID No. 33; (n) the nucleotide sequence shown as SEQ ID No. 35; (o) the nucleotide sequence shown as SEQ ID No. 54; (p) the nucleotide sequence shown as SEQ ID No. 59; (q) the nucleotide sequence shown as SEQ ID No. 62; (r) the nucleotide sequence shown as SEQ ID No. 64; (s) the nucleotide sequence shown as SEQ ID No. 66; (t) the nucleotide sequence shown as SEQ ID No. 68 (u) the nucleotide sequence shown as SEQ ID No. 69 or (v) a nucleotide sequence which has 75% or more identity with any one of the sequences shown as SEQ ID No. 7, SEQ ID No. 8, SEQ ID No. 9, SEQ ID No. 10;      SEQ ID No. 11, SEQ ID No. 13, SEQ ID No. 21, SEQ ID No. 23, SEQ ID No. 25, SEQ ID No. 27, SEQ ID No. 29, SEQ ID No. 31, SEQ ID No. 33, SEQ ID No. 35, SEQ ID No. 54, SEQ ID No. 59, SEQ ID No. 62, SEQ ID No. 64, SEQ ID No. 66, SEQ ID No. 68 or SEQ ID No. 69.  
 
     
 29. Use according to any one of claims 15-28 wherein the fatty-acid CoA independent diglyceride:glycerol acyltransferase is used in combination with a crystallization inhibitor.  
 
     
 30. A method substantially as hereinbefore described with reference to the accompanying description and the figures.  
 
     
 31. A use substantially as hereinbefore described with reference to the accompanying description and figures.  
 
   
 
 
 
 
 
 
 
 
